Almost everythingis done...

We value your privacy

We and our partners use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise ads and content based on your interests, measure the performance of ads and content, and derive insights about the audiences who saw ads and content. Click below to consent to the use of this technology and the processing of your personal data for these purposes. You can change your mind and change your consent choices at any time by returning to this site.

Point of Care

The developed automatic station standardizes and reduces the duration of direct human involvement in the process of CAR-T cells production, as well as increases reproducibility. As a result, the CAR-T therapy can be provided to a larger number of people.

From sketch

Correction of defects caused by changes in the structure of DNA or DNA damages of viral etiology, changing of cell functions is a new and rapidly developing field of gene engineering. The Point оf Care station was designed for adoptive cellular immunotherapy (ACI) carried out by transfer of Т-cells. ACI includes ex vivo expansion of tumor cell-specific T-cells and further reinfusion into a patient’s organism. According to the experts’ point of view, this therapy is one of the most promising methods discovered over the past decade allowing to overcome oncological and autoimmune diseases.

To scale

Do you want the same product under your own brand? Contact us

Already have an idea for what product to create?

Tell us more about it